PRECISION MEDICINE
AND THE FUTURE
OF GENOMICS
PMFG SUMMIT 2025
AND THE FUTURE
OF GENOMICS
PMFG SUMMIT 2025
Day 1
|
|||
|---|---|---|---|
| Time | Session Title / Activity | Details /Speakers | Moderator |
| 07:30-08:45 | Registration & Networking Breakfast | ||
| OPENING SESSION | |||
| 08:45-09:00 | SUMMIT OPENING CEREMONY MC: Fatima Al-Ali, Translational Medicine Scientist, Sidra research Branch, Sidra Medicine, Qatar |
||
| 09:00-09:15 | Opening Keynote Address Mila to Millions |
Julia Vitarello Founder & CEO of Mila’s Miracle Foundation, USA. |
MC |
| 09:15-09:35 | Opening Plenary Lecture Advancing a World-Class Precision Medicine Bioeconomy |
Ed Liu Professor and special fellow of The Jackson Laboratory (JAX), USA |
|
| THE SUMMIT FLAGSHIP OPENING PANEL | |||
| 09:35-10:25 | From Personalized to Population-Scale: Building Thriving Precision Medicine Sector in Qatar |
|
Khalid Fakhro Chief Research Officer, Sidra Medicine, Qatar |
| 10:30-11:00 | Networking Break | ||
| SESSION-1 N-OF-1 Therapies: Precision at the Single Patient Level |
|||
| 11:00-11:25 | Keynote Lecture
Fulfilling the promise of individualizable therapies: from N-of-1 to N-of-Many |
Tim Yu Associate Professor of Pediatrics, Neurogeneticist, Division of Genetics and Genomics, Boston Children’s Hospital; Harvard Medical School, USA |
Calum MacRae Professor of Medicine, Harvard Medical School and Mass General Brigham, USA |
| 11:25-11:45 | Genetically Informed Therapies Spanning Rare Childhood Disorders to Universal Therapeutic Insights | Hakon Hakonarson Director of the Center for Applied Genomics at CHOP and professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania, USA |
|
| Industry Sponsored Fireside Chat | |||
| 11:45-12:05 | Unlocking the next era of population health research in Qatar | Jacob Thaysen CEO, Illumina, USA |
Khalid Fakhro Chief Research Officer, Sidra Medicine, Qatar |
| SESSION-2 Accelerating Genomic Medicine Through Advanced Technologies |
|||
| 12:05-12:20 | Industry Sponsored Talk
The Living Code: AVITI24 and the story of change |
Molly He CEO, Elements Biosciences, USA |
Wouter Hendrickx Director and Principal Investigrator, Pediatric Oncology Translational Research Program, Sidra Medicine, Qatar |
| 12:20-12:30 | Highlight From the Front Lines (Sidra Medicine Core Genomic Lab).
Multi-Omics Integration to Uncover Functional Insights into Patient- Derived Melanoma Model using AVITI24 |
Oleksandr Soloviov Manager, Clinical Genomics Core Facility, Sidra Medicine, Qatar Giusy Gentilcore |
|
| 12:30-01:30 | Lunch Break and Industry Workshop- Concurrent Sessions | ||
| 01:30-01:45 | AWARDING CEREMONY 1 | ||
| SPECIAL KEYNOTE ADDRESS On Data Science |
|||
| 01:45-02:10 | Adventures in Human Genetics: Integrating Genetics, Proteomics & Data Science | Gonçalo Abecasis Vice President & Chief Genomics and Data Science Officer at the Regeneron Genetics Center |
Fowzan Alkuraya CEO, Lifera Omics. KSA |
| Industry Sponsored Fireside Chat | |||
| 02:10-02:30 | Reimagining Innovation in a Data-Driven World: From Labs to Lives | Fidelma Russo Chief Technology Officer, Hewlett Packard Enterprise (HPE) |
Ingrid Fernandez Global head of strategy, HPE, USA |
| Industry Sponsored Talk on Long Read Sequencing | |||
| 02:30-02:45 | Decoding the Complexity of Human Disease with HiFi Sequencing | Neil Ward Vice President and General Manager for Europe, the Middle East, and Africa, PacBio, UK |
Souhaila Al Khodor Director, Perinatal and Reproductive Health Translational Research Program, Sidra Medicine, Qatar |
| SESSION-3 SPECIAL SESSION ON AUTISM PERSONALIZED MEDICINE: Catalyzing Breakthroughs: How Strategic Philanthropy Fuels Precision Autism Research |
|||
| 02:50-03:10 | Plenary Address
The Lurie Autism Institute: A New Model for Transforming Autism Science, Care, and Global Collaboration |
James Dowling Van Meter Professor, Departments of Neurology and Genetics. Director, Penn Neurogenetics Therapy Center University of Pennsylvania/Penn Medicine. Attending Physician, Division of Neurology Children’s Hospital of Philadelphia |
Hilal Lashuel RDI Advisor to the Chairperson of Qatar Foundation and Executive Director of RDI-CPO |
| 03:10-03:30 | Keynote Address
From Autism Gene Discovery to Mechanism-Driven Therapies |
Hakon Hakonarson Director of the Center for Applied Genomics at CHOP and professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania, USA. |
|
| 03:30-04:00 | Networking Break and Travel Award Winner Presentation | ||
| Integrating WGS and RNA-seq for the Diagnosis of a Non-Coding RNU4ATAC Spliceopathy. Mert Pekerbas Izmir Biomedicine and Genome Center, Turkey |
|||
| PANEL DISCUSSION | |||
| 04:00-04:40 | Global Opportunities for Precision Autism Medicine with Worldwide Impact | James Dowling Professor of Pediatrics & Molecular Genetics, the SickKids & University of Toronto, Canada |
Hilal Lashuel RDI Advisor to the Chairperson of Qatar Foundation and Executive Director of RDI-CPO |
| Hakon Hakonarson Director, Center for Applied Genomics, CHOP; Professor of Pediatrics, University of Pennsylvania, USA |
|||
| Madeeha Kamal Acting Division Chief Adolescent Medicine, Sidra Medicine, Qatar |
|||
| Jouke-Jan Hottenga Senior Scientist, Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Qatar |
|||
| Noof Al Sidiqi Lead- National Autism Plan in Ministry of Public Health (MoPH), Qatar. |
|||
| CLOSING PLENNARY LECTURE | |||
| 04:40-05:10 | Genomes, Avatars and AI – the Future of Personalized Medicine | Olivier Elemento Director of the Englander Institute for Precision Medicine Weill Cornell Medicine, NY, USA |
Maha Al Henzab Executive Director, Information Technology, Sidra Medicine |
| 05:10-05-15 | Closing Remarks- Day 1 | ||
Day 2
|
|||
|---|---|---|---|
| Time | Session Title / Activity | Details /Speakers | Moderator |
| 07:30-08:15 | Registration & Networking Breakfast | ||
| Morning Forum Building the Precision Medicine Ecosystem: Research, Technology, and Patient Impact |
|||
| 08:15-08:25 | Sidra’s Medicine Translational Research Programs | Ibrahim Janahi Chief Medical Officer and Chair of Medical Education, Sidra Medicine Khalid Fakhro |
Samir Gupta Division Chief, Neonatology. Sidra Medicine, Qatar AND Patricia Abboud |
| 08:25-08:35 | Metabolic and Mendelian Disorders Translational Research Program, Sidra Medicine | Ammira Akil Director and Principal Investigrator, Metabolic and Mendelian Disorders Translational Research Program, Sidra Medicine, Qatar |
|
| 08:35-08:40 | AGR2 deficiency as a disease and organoid model for gastric intestinal metaplasia | Ahmed Al-Shaibi PhD candidate, Immune Dysregulation Program, Sidra Medicine, Qatar Sidra Medicine, Qatar |
|
| 08:40-08:45 | ETFDH Dysfunction Drives Cardiac and Metabolic Defects | Reem Hasnah Scientist, Congenital Malformations Trnslational Research Program |
|
| 08:45-08:55 | Neuroscience Translatinal Research Program, Sidra Medicine | Younes Mokrab Director and Principal Investigrator, Neuroscience Translatinal Research Program, Sidra Medicine, Qatar |
|
| SESSION-1 OPENING PLENARY LECTURE |
|||
| 08:55-09:20 | Rapid genome sequencing and the future of inpatient precision medicine | Stephen Kingsmore President and CEO of Rady Children’s Institute for Genomic Medicine, USA |
Nicholas Katsanis Co-Founder, Executive VP and Chief Science Officer, Galatea Bio, USA |
| THE CEO PANEL | |||
| 09:20-10:00 | The CEO Panel | Devyn M. Smith CEO, Arbor Biotechnologies, USA |
Iyabo Tinubu-Karch Chief Executives Officer, Sidra Medicine, Qatar |
| Laura Furmanski Partner at Patient Square Capital USA |
|||
| Rama Chakaki President, Qatar Science and Technology Park (QSTP), Qatar |
|||
| Omar Al-Ansari Secretary General, Qatar Research Development and Innovation Council (QRDI), Qatar. |
|||
| Soumaya Ben Beya Dridje General Partner at Rasmal Ventures Qatar |
|||
| Special Keynote Address Featuring Award-Winning Leader in Neurogenetics |
|||
| 10:00-10:30 | Special Keynote Address
The Global Parkinson’s Genetics Program: Building a Global Network. |
Andrew Singleton Lead, the Global Parkinson’s Genetics Program (GP2), USA |
Hilal Lashuel Research Development and Innovation Advisor to the Chairperson of Qatar Foundation, Executive Director of RDI, Qatar Foundation, Qatar |
| 10:30-11:00 | Networking Break | ||
| SESSION-2 Architecting Precision Medicine: Data, Infrastructure, and Intelligent Technologies |
|||
| 11:00-11:20 | Industry Sponsored Focused Presentation Generative Quantum AI: engineering the next generation of precision medicine and genomics. |
Elvira Shishenina Senior Director of Strategic Initiatives. Quantinuum. |
Abdul Rahman Selhab Technical Manager – Genomic Data Science Core, Sidra Medicine, Qatar AND Ehsan Pourkarimi |
| 11:20-11:40 | Industry Sponsored Talk Modernizing Computing for Medical Research: from HPC to Quantum |
Ahmed Al Gatatsheh Lead, IBM Quantum, EMEA, IBM. |
|
| 11:40-12:00 | Industry Sponsored Focused Presentation From Pilot to Population: Advanced Computing That Turns Genomics into a Growth Engine |
Amit Batra Chief AI & Health Transformation Officer, Microsoft, EMEA Microsoft |
|
| 12:00-12:20 | Technology Sponsored Presentation Ozone-Driven Hygiene: A Silent Enabler of Precision Health in Hospital Environments. |
Jake Robinson Compass, Qatar |
|
| 12:30-01:30 | Lunch Time and Industry Workshops | ||
| Special Keynote Address on Data Sharing | |||
| 01:30-01:50 | Towards Responsible International Sharing of Genomic Data: Lessons Learned | Ma’n Zawati Research Director, Centre of Genomics and Policy, McGill University, Canada- Board Member, QPHI, Qatar |
Wadha A. Al-Muftah Chief Medical and Operations Officer, Qatar Precision Health Institute, Qatar |
| SESSION-3 Precision Health in Practice: Global Lessons for Policy & Trust WISH Panel Discussion |
|||
| 01:50-02:30 | Introductory Remarks
Slim Slama, Chief Executive Officer, World Innovation Summit for Health (WISH) Qatar Foundation, Qatar |
Slim Slama Chief Executive Officer, World Innovation Summit for Health (WISH) Qatar Foundation, Qatar |
|
| Building Trust: Policy and Regulation for the Responsible Use of Technology and Genomic Data | Ma’n Zawati Research Director, Centre of Genomics and Policy, McGill University, Canada |
||
| Barry Sulaiman Assistant Professor, Healthcare Law, Hamad bin Khalifa University, Qatar |
|||
| Rita Cerqueira Director of Genetic Diagnostics and Clinical Genomics Laboratory, Portugal. |
|||
| Sponsored Panel Discussion AstraZeneca and BeginNGS Consortium |
|||
| 02:30-03:00 | New Beginnings: Rewriting the story for infants with rare diseases in our region | Maha Zaki Human Genetics and Genome Research Institute, Egypt |
Stephen Kingsmore President and CEO of Rady Children’s Institute for Genomic Medicine, USA |
| Ammira Akil Director, Metabolic and Mendelian Disorders Clinical Research Program, Sidra Medicine, Qatar |
|||
| Abdulrazaq Al-Jazairi Director, the clinical Trials Transformation Division, King Faisal Specialist Hospital, KSA |
|||
| 03:00-03:30 | Networking Break and Travel Award Winner Presentation | ||
| A microRNA signature to personalize drug therapies in type 1 diabetes Hrishikesh Hardikar Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Australia |
|||
| SESSION-4 Global Clinical Trials in Rare Disease Therapies KEYNOTE LECTURE SERIES |
|||
| 03:30-03:50 | Pioneering Precision Clinical Trials in the Middle East: Implementing Novel Therapies for Rare Conditions | Tawfeg Ben Omran Division Chief, Genetic and Genomic Medicine – Sidra Medicine Senior Consultant, Department of Medical Genetics – HMC, Qatar |
Richard Oram Professor of Diabetes and Nephrology, University of Exeter, UK |
| 03:50-04:10 | Keynote Lecture
Developing And Deploying Personalized Gene-Editing Therapies |
Kiran Musunuru Professor for Translational Research, Perelman School of Medicine at the University of Pennsylvania, USA |
|
| 04:10-04:30 | Building Global Networks for Rare Disease Trials | Devyn M. Smith CEO, Arbor Biotechnologies, USA |
|
| 04:30-04:50 | Building Platform Technologies for Rapid Precision Drug Development: The EveryONE Medicines Approach | Srinivas Chunduru Chief Scientific Officer, EveryONE Medicines Inc. USA |
|
| CLOSING PLENARY LECTURE OF DAY 2 | |||
| 05:00-05:30 | Advancing Genomic Insights Through Variant Interpretation | Heidi Rehm Chief genomics officer, Department of Medicine Massachusetts General Hospital (MGH) and Broad Institute |
Hamdi Mbarek Director, Research and Partnerships, QPHI, Qatar. |
| 05:25-05:30 | Closing Remarks of Day 2 | ||
Day 3
|
|||
|---|---|---|---|
| Time | Session Title / Activity | Details /Speakers | Moderator |
| 07:30-08:15 | Registration & Networking Breakfast | ||
| Morning Forum Population-Scale Genomics |
|||
| 08:15-08:45 | Opening Plenary Lecture
Singapore National Precision Medicine Program: Powering Research, Innovation and Enterprise on a National scale |
Patrick Tan Dean (Designate); Senior Vice Dean, Office of Research, Singapore |
Ambroise Wonkam Professor of Genetic Medicine and Director of the McKusick-Nathans Institute, Johns Hopkins University, USA |
| SESSION-1 Global and Regional Expert Insights on Large Scale Genomic Studies and Artificial Intelligence Initiatives KEYNOTE LECTURE SERIES |
|||
| 08:45-09:05 | Rare Lessons, Common Gains: How Rare Diseases Illuminate the Path of Precision Medicine | Fowzan Alkuraya Chief Medical & Genomics Officer, Lifera Omics, KSA |
Tawfeg Ben Omran Division Chief, Genetic and Genomic Medicine – Sidra Medicine Senior Consultant, Department of Medical Genetics – HMC, Qatar AND Sonia Davila |
| 09:05-09:25 | Screening 100,000 Newborns Using Whole Genome Sequencing: The Generation Study | David Bick Principal Clinician, Genomics England and Generation Study, UK Genomics England, UK |
|
| 09:25-09:45 | Harnessing our African Genomes to Improve Health Globally | Ambroise Wonkam Professor of Genetic Medicine and Director of the McKusick-Nathans Institute at School of Medicine, Johns Hopkins University, USA |
|
| 09:45-10:00 | Hamdi Mbarek Director, Research and Partnerships, QPHI, Qatar. |
||
| Panel Discussion calling Genomics for National and Global Precision Medicine |
|||
| 10:00-10:30 | Can Regional Genomic Initiatives Influence Global Health Priorities? | David Bick Principal Clinician, Genomics England and Generation Study, UK |
Sonia Davila Executive Director of Translational Medicine, Sidra Medicine, Qatar AND Reem Al-Sulaiman |
| Ambroise Wonkam Professor of Genetic Medicine and Director of the McKusick-Nathans Institute at School of Medicine, Johns Hopkins University, USA |
|||
| Hamdi Mbarek Director of Research and Partnerships, Qatar Precision Health Institute (QPHI), Qatar |
|||
| Fowzan Alkuraya Chief Medical & Genomics Officer, Lifera Omics, Saudia Arabia |
|||
| Fahad Al-Mulla Chief Scientific Officer& Head of the Translational research Department, Dasman Diabetes Institute- Kuwait |
|||
| 10:30-11:00 | Networking Break and Travel Award Winner Presentation | ||
| Multi-Omics in Precision Medicine: Early Detection of Relapse and Therapy Response Profiling to Guide Clinical Decisions in Pediatric Acute Myeloid Leukemia Borhan Radman Saeed University of Tuebingen, Germany |
|||
| SESSION-2 Enablers of Innovation: Building Qatar’s Research Capacity for Impact |
|||
| 11:00-11:10 | Accelerating Genomic Discovery to Clinical Implementation: QPHI Translational Model | Wadha Al-Muftah Chief Medical and Operations Officer, QPHI, Qatar |
Hamad Ali Yaseen Associate Professor of Genomic Medicine at Kuwait University and Senior Researcher, Dasman Diabetes Institute, Kuwait AND Sandi Deans |
| 11:10-11:20 | QSTP: A National Platform for Transformative Technology and Entrepreneurship | Moza Al-Naemi Business Engagement Lead, Qatar Science and Technology Park (QSTP) |
|
| 11:20-11:30 | QRDI’s Role in Shaping Qatar’s Life Sciences Research and Innovation Landscape | Sara Al Abdulla Senior Scientific Research Program Manager – Biomedical and Health Qatar Research, Development, and Innovation Council (QRDI), Qatar |
|
| 11:30-11:40 | Bioinformatics at UDST: Contributing to Qatar’s Roadmap to Impact” | Mohammad Asif Khan Associate Dean, College of Computing and IT, University of Doha For Scienec and Technology (UDST) |
|
| 11:40-11:50 | Precision Medicine Opportunities: the new paradigm of pediatric and adults’ genetics health | Reem Alsulaiman Chair, Medical Genetics Department, Hamad Medical Corporation |
|
| 11:50-12:00 | Personalized medicine: from rare diseases to cancer | Vladimir Katanaev Scientific Director of the Translational Oncology Research Center, Qatar Biomedical Research Institute, Qatar. |
|
| 12:00-12:10 | High-Resolution Proteomics to Decode Individual Variation | Frank Schmidt Director of the Proteomics Core, Weill Cornell Medicine in Qatar. |
|
| SESSION- 3 INDUSTRY SPONORED TALKS |
|||
| 12:10-12:20 | Industry Sponsored Talk Genomics and AI Innovation: Cisco’s Vision for Next-Gen Precision Medicine |
David Coldwell Global AI Executive, Cisco, USA |
Mark Hughes Chief Commercial Officer, Zetta Genomics, UK |
| 12:20-12:30 | Industry Sponsored Talk The Human Genome Projects in China: From HGP-to-HGP 2 |
Yan LI Beijing Genomics Institute, China |
|
| 12:30-01:30 | Lunch Time and Industry Workshops | ||
| SESSION-4 Precision Snapshots: Fast-Track Scientific Highlights |
|||
| 01:30-01:45 | Cross-species insemination reveals mouse sperm ability to enter and cross the fish micropyle | Fatima Al-Ali Translational Medicine Scientist, Sidra research Branch, Sidra Medicine, Qatar |
Kholoud Al Shafai Scientist, Translational Medicine, Sidra Medicine, Qatar AND Ameera Sadoun |
| Sequential CRISPRi Screens Reveal Cardiomyocyte Development Abnormalities Associated with Congenital Heart Disease Risk Genes | Tasneem A. M. Ebrahim Mindich Child Health and Development Institute & Institute for Regenerative Medicine, Icahn School of Medicine at Mount Sinai, USA |
||
| Combined STR Haplotyping and CMA Strategy for PGT-M of a 113-kb TCOF1 Deletion | Mohthash Musambil Thuriah Medical Center, Saudi Arabia |
||
| From DADA2 Suspicion to LACC1 Deficiency: Integrating Genomics and Functional Studies in Diagnosing Autoinflammation. | Rafah Mackeh Staff Scientisti, Immune Dysregulation Program, Sidra Medicine, Qatar |
||
| Unveiling the Genetic Architecture of Monogenic childhood Obesity in Qatar | Idris Mohammed Postdoctoral Fellow, Precision Genomics and Translational Omics Lab |
||
| Precision Medicine Landscape of Parkinson’s disease in Emiratis Revealed by Multi-Omics Analysis and de novo assembly building | Dia Advani Mohammed Bin Rashid University of Medicine and Health Sciences, UAE |
||
| Reanalysis of unresolved rare genetic disorders in a pediatric cohort through long-read sequencing | Amal Ibrahim Qatar University |
||
| Industry Partner Spotlight | |||
| 01:45-02:00 | Next-Gen Therapies for Patient Impact | Chiara Cugno Director – Advanced Cell Therapy Core, Sidra Medicine, Qatar. |
Essam Abdelalim Principal Investigator, Translational Medicine, Sidra Medicine, Qatar |
| SESSION-5 Enabling Innovation and Investment in Qatar’s Knowledge Economy |
|||
| 02:00-02:15 | Qatar Free Zone | Sara Al-Jassim Associate – Business Development, QFZ, Qatar |
Luis Saraiva Principal Investigator, Translational Medicine, Sidra Medicine, Qatar |
| 02-15-02:30 | Invest Qatar | Nasser Ali Al-Kaabi Senior Specialist Investor Relations Invest Qatar |
|
| SESSION-6 Integrating Genomic Discovery, AI, and Therapeutic Development into Clinical Practice |
|||
| 02:30-02:50 | AI-driven integration of drug discovery and development into routine clinical care | Calum MacRae Vice Chair for Scientific Innovation, Department of Medicine, Brigham and Women’s Hospital and Associate Professor of Medicine at Harvard Medical School, USA |
Abubakr Imam Division Chief, Nephrology and Hypertension, Sidra Medicine, Qatar |
| 02:50-03:10 | Developmental and Disease-Related Remodeling of HSC Identity | Ana Cvejic Professor, Biotechnology Research and Innovation Centre (BRIC), University of Copenhagen, Denmark |
|
| 03:10-03:40 | NETWORKING BREAK AND AWARDING CEREMONY 2 | ||
| SESSION-6 (Cont.) | |||
| 03:40-03:50 | Using AI for Precision Medicine at Scale: a perspective from industry | Joseph Lehar Advisor to biotechs’ and venture funds |
Bernice Lo Director and Principal Investigrator, Immune Dysregulation Program, Sidra Medicine, Qatar |
| 03:50-04:10 | Advanced genomic approaches for rare and undiagnosed diseases. Insights into improving diagnostic outcomes | Uğur Özbek Director, Rare and Undiagnosed Disease Platform IBG-Izmir Biomedicine and Genome Center, Turkey |
|
| 04:10-04:30 | From Populations to Cells: Precision Health Through Human Molecular Profiling at Scale | Claudia Langenberg Director, the Precision Healthcare University Research Institute at Queen Mary University of London, UK. |
|
| SESSION-7 CLOSING DEBATE |
|||
| 04:30-05:00 | We’ve Sequenced a Nation — What Comes Next? | Nicholas Katsanis Co-Founder, Executive VP, and Chief Science Officer, Galatea Bio, USA Manolis Dermitzakis |
Ammira Akil Director and Principal Investigrator, Metabolic and Mendelian Disorders Clinical Research Program, Sidra Medicine, Qatar |
| THE SUMMIT CLOSING CEREMONY | |||
| Reflections: The Takeaways- Khalid Fakhro– Chief Research Officer, Sidra Medicine | |||
| PMFG 2026 Announcement | |||